✦ LIBER ✦

Development of GPIIb/IIIa antagonists as antithrombotic drugs

✍ Scribed by Andrew J. Nichols; Robert R. Ruffolo Jr; William F. Huffman; George Poste; James Samanen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet GPIIB/IIIA antagonists: How saf

✍ S.A. Mousa; W.F. De Grado; T.M. Reilly 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Tetrahydrothienopyridine derivatives as

✍ Kiyoaki Katano; Eiki Shitara; Masaro Shimizu; Kazue Sasaki; Tomoaki Miura; Yasuk 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 233 KB

ChemInform Abstract: Tetrahydrothienopyr

✍ K. KATANO; E. SHITARA; M. SHIMIZU; K. SASAKI; T. MIURA; Y. ISOMURA; M. KAWAGUCHI 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 27 KB

Intranasal Antiplatelet/ Antithrombotic

✍ Shaker A Mousa; Dun-Xu Mu; Munir A Hussain 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Thromboxane A2 synthase inhibitor enhanc

✍ Ken-ichi Kawano; Kazuya Hokamura; Kazunao Kondo; Yasuhiko Ikeda; Yasuhiro Suzuki 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 650 KB

Antiplatelet and Antithrombotic Effects

✍ Taketoshi Ogawa; Atsuhiro Sugidachi; Hideo Naganuma; Fumitoshi Asai 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 209 KB